DK3010535T3 - Toxoide peptider afledt fra fenol opløselige modulin, delta toxin, superantigener og fusioner deraf - Google Patents
Toxoide peptider afledt fra fenol opløselige modulin, delta toxin, superantigener og fusioner deraf Download PDFInfo
- Publication number
- DK3010535T3 DK3010535T3 DK14813512.2T DK14813512T DK3010535T3 DK 3010535 T3 DK3010535 T3 DK 3010535T3 DK 14813512 T DK14813512 T DK 14813512T DK 3010535 T3 DK3010535 T3 DK 3010535T3
- Authority
- DK
- Denmark
- Prior art keywords
- toxoide
- superantigenes
- phenole
- fusions
- peptides derived
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361836959P | 2013-06-19 | 2013-06-19 | |
PCT/US2014/042999 WO2014205111A1 (en) | 2013-06-19 | 2014-06-18 | Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3010535T3 true DK3010535T3 (da) | 2020-11-30 |
Family
ID=52105236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK14813512.2T DK3010535T3 (da) | 2013-06-19 | 2014-06-18 | Toxoide peptider afledt fra fenol opløselige modulin, delta toxin, superantigener og fusioner deraf |
Country Status (7)
Country | Link |
---|---|
US (2) | US9815872B2 (ja) |
EP (1) | EP3010535B1 (ja) |
JP (1) | JP6632974B2 (ja) |
CA (1) | CA2916231C (ja) |
DK (1) | DK3010535T3 (ja) |
PT (1) | PT3010535T (ja) |
WO (1) | WO2014205111A1 (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6632974B2 (ja) | 2013-06-19 | 2020-01-22 | インテグレイテッド バイオセラピューティクス,インコーポレイテッド | フェノール可溶性モジュリン、δ毒素、スーパー抗原に由来するトキソイドペプチド、およびその融合物 |
US10717766B2 (en) | 2016-08-22 | 2020-07-21 | Technion Research & Development Foundation Limited | Antimicrobial peptides and uses thereof |
WO2018081350A1 (en) * | 2016-10-27 | 2018-05-03 | Medimmune, Llc | Signal polypeptide for improved secretion of protein |
CN107224575B (zh) * | 2017-03-06 | 2018-11-09 | 浙江海隆生物科技有限公司 | 奶牛金黄色葡萄球菌***炎亚单位疫苗的组合物及其制备方法和应用 |
CA3069747A1 (en) * | 2017-07-27 | 2019-01-31 | Mohammad Javad Aman | Immunogenic composition comprising a fusion peptide derived from superantigen toxoids |
KR20220132641A (ko) | 2020-12-18 | 2022-09-30 | 비오메디찌니쉐 포르슝 운트 바이오-프로듀테 아게 | 보호성 스타필로코커스 외독소 백신 |
GR1010289B (el) * | 2021-04-27 | 2022-08-29 | Integrated Biotherapeutic Vaccines, Inc., | Τοξοειδη πεπτιδια που προερχονται απο διαλυτη σε φαινολη μοδουλινη, τοξινη δελτα, υπεραντιγονα και συντηξεις αυτων |
CN113234125B (zh) * | 2021-05-10 | 2022-12-06 | 华东理工大学 | 自组装多肽、多肽水凝胶及其制备方法和用途 |
WO2023227563A1 (en) | 2022-05-23 | 2023-11-30 | Biomedizinische Forschung & Bio-Produkte AG | Protective staphylococcal exotoxin vaccine |
WO2023247747A1 (en) | 2022-06-23 | 2023-12-28 | Biomedizinische Forschung & Bio-Produkte AG | Protective staphylococcal exotoxin vaccine |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US6593114B1 (en) * | 1996-01-05 | 2003-07-15 | Human Genome Sciences, Inc. | Staphylococcus aureus polynucleotides and sequences |
TW517061B (en) * | 1996-03-29 | 2003-01-11 | Pharmacia & Amp Upjohn Ab | Modified/chimeric superantigens and their use |
US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
US6713284B2 (en) | 1997-06-25 | 2004-03-30 | The United States Of America As Represented By The Secretary Of The Army | Bacterial superantigen vaccines |
US7087235B2 (en) | 1997-06-25 | 2006-08-08 | The United States Of America As Represented By The Secretary Of The Army | Fusion protein of streptococcal pyrogenic exotoxins |
US6632640B1 (en) * | 1998-07-10 | 2003-10-14 | The United States Of America As Represented By The Secretary Of The Army | Vaccine against Staphylococcus intoxication |
GB0118155D0 (en) | 2001-07-25 | 2001-09-19 | Lorantis Ltd | Superantigen |
CN102366630B (zh) * | 2003-03-07 | 2015-04-01 | 惠氏控股公司 | 用于抗医院内感染的免疫的多糖-葡萄球菌表面粘附素载体蛋白缀合物 |
US20050008633A1 (en) | 2003-05-19 | 2005-01-13 | Advanced Inhalation Research Inc. | Chemical and physical modulators of bioavailability of inhaled compositions |
US7754225B2 (en) | 2006-07-20 | 2010-07-13 | Glaxosmithkline Biologicals S.A. | Method of protecting against staphylococcal infection |
EP2178904B1 (en) * | 2007-06-06 | 2016-11-02 | The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services | Psm peptides as vaccine targets against methicillin-resistant staphylococcus aureus |
JP5658564B2 (ja) * | 2007-08-31 | 2015-01-28 | ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago | ブドウ球菌肺疾患および状態に対する免疫に関連した方法および組成物 |
EP2672989A4 (en) | 2011-02-08 | 2015-03-11 | Integrated Biotherapeutics Inc | IMMUNOGENIC COMPOSITION WITH ALPHA-HEMOLYSIN OLIGOPEPTIDES |
US9789176B2 (en) * | 2011-03-16 | 2017-10-17 | Regents Of The University Of Minnesota | Compositions and methods for inducing immune responses against bacteria in the genus staphylococcus |
US10023848B2 (en) | 2011-12-02 | 2018-07-17 | Integrated Biotherapeutics, Inc | Immunogenic composition comprising Panton-Valentine Leukocidin (PVL) derived polypeptides |
JP6632974B2 (ja) | 2013-06-19 | 2020-01-22 | インテグレイテッド バイオセラピューティクス,インコーポレイテッド | フェノール可溶性モジュリン、δ毒素、スーパー抗原に由来するトキソイドペプチド、およびその融合物 |
-
2014
- 2014-06-18 JP JP2016521549A patent/JP6632974B2/ja active Active
- 2014-06-18 WO PCT/US2014/042999 patent/WO2014205111A1/en active Application Filing
- 2014-06-18 PT PT148135122T patent/PT3010535T/pt unknown
- 2014-06-18 EP EP14813512.2A patent/EP3010535B1/en active Active
- 2014-06-18 US US14/899,993 patent/US9815872B2/en active Active
- 2014-06-18 CA CA2916231A patent/CA2916231C/en active Active
- 2014-06-18 DK DK14813512.2T patent/DK3010535T3/da active
-
2017
- 2017-11-13 US US15/810,419 patent/US10174085B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3010535A4 (en) | 2017-03-01 |
CA2916231A1 (en) | 2014-12-24 |
EP3010535B1 (en) | 2019-08-14 |
CA2916231C (en) | 2024-02-06 |
US20160185829A1 (en) | 2016-06-30 |
JP2016522259A (ja) | 2016-07-28 |
JP6632974B2 (ja) | 2020-01-22 |
PT3010535T (pt) | 2020-07-03 |
WO2014205111A1 (en) | 2014-12-24 |
US9815872B2 (en) | 2017-11-14 |
EP3010535A1 (en) | 2016-04-27 |
US10174085B2 (en) | 2019-01-08 |
US20180148482A1 (en) | 2018-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3010535T3 (da) | Toxoide peptider afledt fra fenol opløselige modulin, delta toxin, superantigener og fusioner deraf | |
HK1225641A1 (zh) | Gitr抗原結合蛋白 | |
DK3107938T3 (da) | Modificerede, antigenbindende polypeptidkonstrukter og anvendelser heraf | |
DK3027204T3 (da) | Flerdelte signaleringsproteiner og anvendelser deraf | |
DK3076813T3 (da) | Nikotinholdig ikke-tobaksgenstand | |
DK3683235T3 (da) | Anti-IL-33-antistoffer og anvendelser deraf | |
DK3008168T3 (da) | Sc-celler og sammensætninger og fremgangsmåde til dannelse deraf | |
DK3043784T3 (da) | Arylethere og anvendelser deraf | |
DK2970464T3 (da) | Anti-lag-3-bindende proteiner | |
DK2951203T3 (da) | Heterodimere proteiner | |
DK3019533T3 (da) | Dobbeltspiraliserede immunoglobulinfusionproteiner og sammensætninger deraf | |
DK3079719T3 (da) | ANTI-SIGLEC-8-antistoffer og fremgangsmåder til anvendelse deraf | |
DK3300610T3 (da) | Fremgangsmåde til fraktionering af opløselige ærter | |
DK2976084T3 (da) | Kombination, der omfatter zidovudin og polymyxin | |
DK3065771T3 (da) | Fremgangsmåder og sammensætninger til vedvarende immunterapi | |
DK2962100T3 (da) | Tuberkulosebiomarkører og anvendelser deraf | |
FR3016213B1 (fr) | Capteur de gaz miniature. | |
DK2964767T3 (da) | Toksingener og fremgangsmåder til anvendelse deraf | |
DK3089760T3 (da) | Konstrukt og sekvens til forbedret genekspression | |
DK2952033T3 (da) | Beskyttelsessystem til trådløs NLOS-backhaul | |
DK2983704T3 (da) | Fusionspolypeptider og vacciner | |
DK3079476T3 (da) | Syreopløselige kobber-ammonium-komplekser og kobber-zink-ammonium-komplekser, sammensætninger, præparat, metoder og anvendelse | |
DK2970944T3 (da) | Kntc2-peptider og vacciner, der indeholder disse | |
DK3110837T3 (da) | Tatk-cdkl5-fusionsproteiner, sammensætninger, formule-ringer og anvendelse deraf | |
DK3421092T3 (da) | Anti-regurgationssammensætning, der bevarer tarmmotiliteten |